跳至主要内容
临床试验/TCTR20240605006
TCTR20240605006尚未招募2 期

Combined cystatin C and creatinine based estimated glomerular filtration rate for COListin Dosing on Prevention of Acute Kidney Injury: a randomized controlled trial

Excellence Center for Critical Care Nephrology, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 134 人开始时间: 2024年6月5日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
134

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Enrolled within 24 hours after the first dose of colistin and expected colistin duration >=48 hours)
  • 2. At risk of low muscle mass defined by sarcopenia index <80%

排除标准

  • 1. AKI any stage by KDIGO criteria 2012
  • 2. End stage kidney disease
  • 3. History of kidney transplant
  • 4. Pregnancy
  • 5. Received any routes of colistin within 14 days prior to the day of enrollment
  • 6. Expected death within 48 hours

研究者

发起方
Excellence Center for Critical Care Nephrology, Faculty of Medicine, Chulalongkorn University

相似试验